Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
PCSA similar filings
- 6 Oct 20 Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
- 27 Aug 20 Entry into a Material Definitive Agreement
- 20 Aug 20 Entry into a Material Definitive Agreement
- 1 Jun 20 Entry into a Material Definitive Agreement
- 27 May 20 Regulation FD Disclosure
- 30 Mar 20 Processa Pharmaceuticals to Move Forward with a PCS499 Phase 3 Trial after a Successful Fda Meeting
- 17 Mar 20 Processa Pharmaceuticals Announces Results from the Phase 2 Study In Necrobiosis Lipoidica
Filing view
External links